Sheehan D V, Zak J P, Miller J A, Fanous B S
Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine, Tampa 33613.
J Clin Psychiatry. 1988 Aug;49 Suppl:30-6.
The authors review the role of the serotonergic system in panic disorder and the potential for use of the new serotonin (5-HT) reuptake inhibitors in treating panic disorder. Data currently available are only preliminary but suggest a future potential for this class of drug in the treatment of panic/anxiety disorders. The authors present a succinct and comprehensive overview of the data available, which aims to assist in the planning of future research in this area.
作者回顾了血清素能系统在惊恐障碍中的作用,以及新型血清素(5-羟色胺)再摄取抑制剂用于治疗惊恐障碍的潜力。目前可得的数据仅为初步数据,但表明这类药物在治疗惊恐/焦虑症方面具有未来潜力。作者对现有数据进行了简洁而全面的概述,旨在为该领域未来的研究规划提供帮助。